The hottest medical plastic products are becoming

Medical plastic products are becoming more and more important in the medical industry

at present, the innovation ability of domestic medical plastic products industry in technology and products is relatively weak, and there are relatively few products with independent intellectual property rights. With the development of China's economy, the continuous improvement of people's quality of life and the lasting demand for medical products, the market prospect of China's medical plastic industry is extremely broad. After joining the WTO, we are facing opportunities and challenges. We have reason to believe that China's medical plastic industry will have a rapid development in the near future

with the development of medical devices in the past 20 years, medical plastic products have played a more and more important role in the medical industry. In 1997, the output value of medical devices in the world reached 137billion US dollars, and medical plastic products accounted for 15% of its share. The total output value of medical devices in China reached 30billion yuan in 2000, and medical plastic products was about 4billion yuan. In 1999, 5700 medical device enterprises were registered nationwide, while more than 600 enterprises produced medical plastic products, accounting for 10%

according to the statistics, medical plastic products in China have developed rapidly in the past 10 years, while there are few high-tech fields. It is estimated that the medical device market in China will grow by 40% by 2005, and then the medical plastic products can grow year on year, with great market potential. There is still a big gap between China's medical plastic products and the advanced level of foreign countries, mainly in the following aspects

1. Due to the backward basic industry, the categories of raw materials required for medical plastic products are incomplete, the quality standards are not standardized, and there is a lack of enterprises developing medical plastic products raw materials, such as medical polyurethane material, one of the best materials for interventional therapy catheter, which is difficult to buy in the market and can only be imported abroad. Therefore, most of the catheter materials in China are PVC materials, and there is a certain gap between the performance and quality of its products and imported similar products, So that domestic products lack the ability to compete with imported products in market promotion

in addition, dialyzers and oxygenators are mature products in medical clinic. The materials they use cannot be separated from medical Pu as the potting material of hollow fiber membrane. The annual consumption of medical P will continue to bear tens of tons of newly increased capital u materials, all of which depend on imports. Therefore, the development of medical polyurethane materials is also an important topic in the plastic chemical industry to solve the localization of medical PU materials, It is of great significance to promote the development of medical plastic products. 2. The basic facilities of medical plastic products manufacturing enterprises have low management level, poor stability and reliability of product quality. There are nearly 600 enterprises producing medical plastic products across the country. After being amplified by high-speed amplifiers, many of them have backward infrastructure, fail to fully comply with the production and management specifications of disposable sterile medical devices, backward processing equipment, low quality of management personnel, even workshop style labor-intensive, the production environment can not meet GMP standards, and the technical force is weak, which has hindered the development of medical plastic enterprises in China. Therefore, Domestic medical plastic products often have continuous quality problems. Although the state medical administration has increased supervision, punishment and crackdown on counterfeiting, in order to make China's medical plastic enterprises have a rapid development, enterprises must do according to laws and regulations, pass ISO9000 quality system certification, standardize enterprise behavior, and improve quality awareness

3. The technical structure of products lags behind the development of contemporary science and technology. The technical performance of most materials and products belongs to medium and low-grade products. A considerable number of production enterprises that have not formed economies of scale cannot participate in the competition as foreign enterprises do in full accordance with the rules of market economy, and the labor productivity of all employees is low, lacking market competitiveness

4. Select areas with good domestic basic conditions, through the efforts of enterprises and the support of government policies, and through the joint establishment of several industrial centers integrating development, research, production and marketing, to compete with foreign enterprises in some key products that affect the national economy, so as to cope with the competitive pressure faced by Chinese enterprises after China's entry into WTO. According to the track of market economy, we should pay attention to the biomedical medical plastic industry, limit the increase of low value-added and low technology product enterprises, focus on supporting several large-scale enterprises with good basic conditions, eliminate backward small and medium-sized enterprises, and establish a competitive mechanism of survival of the fittest

5. In recent years, China's medical plastic industry has developed rapidly, increasing at an average rate of 15% to 20% per year. However, domestic medical plastic products are an emerging industry, with a low starting point and a large gap compared with international advanced countries. For example, in 1982, China's medical plastic output value was only 78 million yuan, and the requirements for experimenters were not high, less than 100 million yuan. Even if the output value of medical plastics increased to 3billion in 1997, and the output value of medical devices was 24billion. Medical plastic products accounted for 12.5% of its share. In 1999, the output value of medical plastics was 3.8 billion, accounting for only 1% to 2% of the world's output value of medical plastics, and the domestic per capita consumption was only 1% to 5% of that of foreign developed countries

note: the reprinted content is indicated with the source. The reprint is for the purpose of transmitting more information, and does not mean to agree with its views or confirm the authenticity of its content